Comment
. 2008 Jan 5;371(9606):25; author reply 26.
doi: 10.1016/S0140-6736(08)60060-4.
The ADVANCE trial
- PMID: 18177767
- DOI: 10.1016/S0140-6736(08)60060-4
Item in Clipboard
Comment
The ADVANCE trial
Lancet.
.
No abstract available
Comment on
-
Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial.Lancet. 2007 Sep 8;370(9590):829-40. doi: 10.1016/S0140-6736(07)61303-8. Lancet. 2007. PMID: 17765963 Clinical Trial.
Similar articles
-
[Hypertension, heart failure, myocardial infarction, secondary prevention: the role of perindopril].Ital Heart J. 2005 Nov;6 Suppl 7:40S-47S. Ital Heart J. 2005. PMID: 16485516 Review. Italian.
-
The ADVANCE trial.Lancet. 2008 Jan 5;371(9606):25-6; author reply 26. doi: 10.1016/S0140-6736(08)60061-6. Lancet. 2008. PMID: 18177766 No abstract available.
-
Not all angiotensin-converting enzyme inhibitors are equal: focus on ramipril and perindopril.Postgrad Med. 2013 Jul;125(4):154-68. doi: 10.3810/pgm.2013.07.2687. Postgrad Med. 2013. PMID: 23933903 Review.
-
The EUROPA trial.Lancet. 2003 Dec 6;362(9399):1935; author reply 1936-7. doi: 10.1016/S0140-6736(03)14971-9. Lancet. 2003. PMID: 14667756 No abstract available.
-
[Need of tight blood pressure control in type 2 diabetes. The intervention study ADVANCE gives clear information].Lakartidningen. 2007 Oct 17-23;104(42):3028-9. Lakartidningen. 2007. PMID: 17985709 Swedish. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
